Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)
Learn more about:
Related Clinical Trial
Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy
Fat and Glucose Metabolism in Fed and Fasted State in Patients With Low Skeletal Muscle Mass
A Study of CK-2127107 in Patients With Spinal Muscular Atrophy
Spinal Muscular Atrophy and Cardiac Autonomic Function
Effect of Nusinersen on Adults With Spinal Muscular Atrophy
Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)